ClinConnect ClinConnect Logo
Search / Trial NCT04529330

The Research About Acute Compartment Syndrome

Launched by HEBEI MEDICAL UNIVERSITY THIRD HOSPITAL · Aug 25, 2020

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Acs Tibial Plateau Fractures Tibial Shaft Fractures

ClinConnect Summary

This clinical trial is studying Acute Compartment Syndrome (ACS), a condition that can occur after an injury, like a fracture, where pressure builds up in a muscle compartment, potentially leading to serious complications. The goal of the trial is to better understand how to diagnose and treat ACS effectively. Researchers are particularly interested in the best ways to measure and identify the condition, as there is still some disagreement among doctors about the most reliable methods.

To participate in this trial, individuals need to be over 18 years old and have specific types of knee fractures known as Schatzker V and VI. Unfortunately, younger patients, those with certain other injuries, or those who have already been treated with different methods will not be eligible. Participants can expect to undergo evaluations regarding their condition and may receive different treatment approaches as part of the study. This trial aims to improve outcomes for patients with ACS and help doctors make better decisions in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Fracture patients with Schatzker V and VI,
  • Who were older than eighteen years.
  • Exclusion Criteria:
  • The exclusion criteria were pathologic, extra-articular proximal tibial fracture,
  • Patients who was eighteen years or younger.
  • Patients treated with other implant,
  • underwent conservative management were also excluded.

About Hebei Medical University Third Hospital

Hebei Medical University Third Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care. As a prominent clinical trial sponsor, the hospital focuses on innovative therapies and evidence-based practices across various medical fields. With a commitment to ethical standards and patient safety, the institution collaborates with multidisciplinary teams to conduct rigorous clinical studies that contribute to the scientific community and enhance treatment options. Leveraging state-of-the-art facilities and a patient-centric approach, Hebei Medical University Third Hospital plays a vital role in the advancement of clinical research and the development of new healthcare solutions.

Locations

Shijiazhuang, Hebei, China

Patients applied

0 patients applied

Trial Officials

Hou Zhiyong, Doctor

Principal Investigator

Hebei Medical University Third Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials